Document is current
Any future updates will be listed below
-
Authors
Hansson, Oskar http://orcid.org/0000-0001-8467-7286
Jack, Clifford R. Jr. http://orcid.org/0000-0001-7916-622X
- License Information
-
More Information
Article History
First Online: 15 July 2024
Competing interests
: O.H. has acquired research support (for the institution) from AVID Radiopharmaceuticals, Biogen, C2N Diagnostics, Eli Lilly, Eisai, Fujirebio, GE Healthcare, and Roche. In the past 2 years, he has received consultancy/speaker fees from Alzpath, BioArctic, Biogen, Bristol Meyer Squibb, Eisai, Eli Lilly, Fujirebio, Merck, Novartis, Novo Nordisk, Roche, Sanofi and Siemens. C.R.J. declares no competing interests.
